Font Size: a A A
Keyword [Leukemia, myeloid, chronic]
Result: 1 - 20 | Page: 1 of 2
1. Expansion Of Dendritic Cells From Normal And Chronic Myelogenous Leukemic CD34~+ Progenitor Cells
2. Chronic Myeloid Leukemia Dendritic Cell Vaccine Mediated By The Specific Anti-leukemia Effect
3. Expression Levels Of Phosphorylated P210bcr/abl Protein And Hsp90 Protein In Apoptosis Induced By Berbamine In K562 Cells
4. Monitoring BCR/ABL Transcript Levels After Hematopoietic Stem Cells Transplantation By Real-time RT-PCR
5. Clinical And Experimental Studies Of Derivative Chromosome 9 Deletion In Patients With Ph-positive Leukemia
6. The Effect Of Imatinib Mesylate Therapy On Ph Chromosome And Bcr/abl Gene Expression In Patients With CML
7. Resistive Ling Capsules Treatment Of Chronic Myeloid Leukemia Observed
8. The Experession Of FoxO3a Transcription Fator And Bcr-abl Fusion Gene In The Patients With Chronic Myeloid Leukemia And Its Clinincal Signifiance
9. The Expression And Clinical Significance Of Mcl-1 And Bar/abl Genes In Chronic Myeloid Leukemia
10. Expression Of Nrf2 In Chronic Myeloid Leukemia And Its Correlation With Trxr
11. Investigation Of66Patients With Chronic Myeloid Leukemia Receiving Imatinib
12. Effect Of Nrf2by SiRNA Inhibits On Chemoresistance In Imatinib-resistant K562/G01Cells
13. Sirna Interference Nrf2Reversed Resistance Mechanisms Of Imatinib-resistant Cell Lines K562/G01Research
14. Detection Of Cytogenetic And Molecular Biology In Chronic Myeloid Leukemia Patients
15. The Clinical Effect And Drug Resistence In Chronic Myeloid Leukemia Patients Treated With Imatinib
16. 1、Study On The Change Of Thyroid Function In Patients With Iron Deficiency Anemia 2、Meta-analysis Of DAS And IM For Chronic-phase Chronic Myeloid Leukemia
17. Patient Adherence To Imatinib Therapy In Chronic Phrase Of Chronic Myeloid Leukemia
18. Clinical Observation Of Nilotinib In Patients With Imatinib-resistant Or Intolerant Chronic Myeloid Leukemia
19. Clinical Observation And Analysis Of Generic Imatinib Mesylate Capsules Produced In China For Newly Diagnosed CML Patients
20. Analysis Of ABL Kinase Domain Mutations In The Patients With Progressive Chronic Myeloid Leukemia
  <<First  <Prev  Next>  Last>>  Jump to